Susquehanna International Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.1M | Buy |
454,300
+162,200
| +56% | +$12.8M | ﹤0.01% | 1607 |
|
|
2025
Q4 | $23.1M | Buy |
292,100
+85,400
| +41% | +$6.43M | ﹤0.01% | 2054 |
|
|
2025
Q3 | $13.5M | Buy |
206,700
+109,400
| +112% | +$5.34M | ﹤0.01% | 2631 |
|
|
2025
Q2 | $3.84M | Buy |
97,300
+800
| +0.8% | +$26.2K | ﹤0.01% | 4476 |
|
|
2025
Q1 | $2.91M | Sell |
96,500
-7,800
| -7% | -$255K | ﹤0.01% | 4710 |
|
|
2024
Q4 | $3.65M | Buy |
104,300
+45,600
| +78% | +$1.7M | ﹤0.01% | 4104 |
|
|
2024
Q3 | $2.35M | Sell |
58,700
-63,000
| -52% | -$2.93M | ﹤0.01% | 4972 |
|
|
2024
Q2 | $5.8M | Sell |
121,700
-69,700
| -36% | -$2.86M | ﹤0.01% | 3208 |
|
|
2024
Q1 | $8.3M | Buy |
191,400
+34,700
| +22% | +$1.65M | ﹤0.01% | 2885 |
|
|
2023
Q4 | $7.93M | Buy |
156,700
+40,500
| +35% | +$1.94M | ﹤0.01% | 2975 |
|
|
2023
Q3 | $5.27M | Sell |
116,200
-31,800
| -21% | -$1.31M | ﹤0.01% | 3426 |
|
|
2023
Q2 | $6.07M | Buy |
148,000
+107,300
| +264% | +$4.12M | ﹤0.01% | 3212 |
|
|
2023
Q1 | $1.45M | Sell |
40,700
-25,500
| -39% | -$958K | ﹤0.01% | 5875 |
|
|
2022
Q4 | $2.5M | Sell |
66,200
-15,600
| -19% | -$656K | ﹤0.01% | 4319 |
|
|
2022
Q3 | $3.62M | Sell |
81,800
-11,000
| -12% | -$463K | ﹤0.01% | 3716 |
|
|
2022
Q2 | $3.44M | Sell |
92,800
-36,900
| -28% | -$1.39M | ﹤0.01% | 3831 |
|
|
2022
Q1 | $4.8M | Sell |
129,700
-62,100
| -32% | -$2.03M | ﹤0.01% | 3701 |
|
|
2021
Q4 | $5.84M | Buy |
191,800
+50,900
| +36% | +$1.6M | ﹤0.01% | 3491 |
|
|
2021
Q3 | $4.73M | Sell |
140,900
-91,800
| -39% | -$3.46M | ﹤0.01% | 4051 |
|
|
2021
Q2 | $9.28M | Sell |
232,700
-3,100
| -1% | -$121K | ﹤0.01% | 3028 |
|
|
2021
Q1 | $10.6M | Buy |
235,800
+100,200
| +74% | +$5.59M | ﹤0.01% | 2681 |
|
|
2020
Q4 | $7.67M | Sell |
135,600
-23,500
| -15% | -$1.17M | ﹤0.01% | 2826 |
|
|
2020
Q3 | $7.55M | Sell |
159,100
-21,000
| -12% | -$1.17M | ﹤0.01% | 2549 |
|
|
2020
Q2 | $10.6M | Sell |
180,100
-90,700
| -33% | -$5.05M | ﹤0.01% | 2063 |
|
|
2020
Q1 | $12.8M | Sell |
270,800
-421,300
| -61% | -$23.5M | ﹤0.01% | 1509 |
|
|
2019
Q4 | $41.8M | Buy |
692,100
+14,300
| +2% | +$852K | 0.01% | 928 |
|
|
2019
Q3 | $40.6M | Buy |
677,800
+242,400
| +56% | +$15.8M | 0.01% | 859 |
|
|
2019
Q2 | $28M | Sell |
435,400
-295,700
| -40% | -$20.9M | 0.01% | 1053 |
|
|
2019
Q1 | $59.3M | Buy |
731,100
+247,800
| +51% | +$16M | 0.02% | 537 |
|
|
2018
Q4 | $26.1M | Sell |
483,300
-264,000
| -35% | -$13.5M | 0.01% | 927 |
|
|
2018
Q3 | $38.5M | Buy |
747,300
+166,100
| +29% | +$7.8M | 0.01% | 843 |
|
|
2018
Q2 | $24.2M | Buy |
581,200
+169,100
| +41% | +$7.5M | 0.01% | 1151 |
|
|
2018
Q1 | $18.2M | Sell |
412,100
-27,000
| -6% | -$1.37M | 0.01% | 1286 |
|
|
2017
Q4 | $22.1M | Sell |
439,100
-145,500
| -25% | -$7.98M | 0.01% | 1183 |
|
|
2017
Q3 | $29.6M | Buy |
584,600
+121,700
| +26% | +$6.37M | 0.01% | 954 |
|
|
2017
Q2 | $23.5M | Sell |
462,900
-29,400
| -6% | -$1.37M | 0.01% | 1037 |
|
|
2017
Q1 | $19.8M | Sell |
492,300
-172,300
| -26% | -$7.74M | 0.01% | 1073 |
|
|
2016
Q4 | $31.8M | Sell |
664,600
-34,700
| -5% | -$1.37M | 0.02% | 766 |
|
|
2016
Q3 | $25.6M | Sell |
699,300
-26,900
| -4% | -$842K | 0.01% | 855 |
|
|
2016
Q2 | $16.9M | Buy |
726,200
+153,700
| +27% | +$4.96M | 0.01% | 1083 |
|
|
2016
Q1 | $23.2M | Sell |
572,500
-294,400
| -34% | -$12M | 0.01% | 908 |
|
|
2015
Q4 | $53.7M | Sell |
866,900
-74,100
| -8% | -$4M | 0.02% | 571 |
|
|
2015
Q3 | $38M | Sell |
941,000
-218,900
| -19% | -$11.3M | 0.02% | 781 |
|
|
2015
Q2 | $66.8M | Buy |
1,159,900
+88,200
| +8% | +$5.61M | 0.03% | 543 |
|
|
2015
Q1 | $68.2M | Sell |
1,071,700
-66,300
| -6% | -$4.5M | 0.03% | 505 |
|
|
2014
Q4 | $70.3M | Sell |
1,138,000
-238,700
| -17% | -$11.8M | 0.03% | 551 |
|
|
2014
Q3 | $53.5M | Buy |
1,376,700
+95,000
| +7% | +$3.37M | 0.02% | 712 |
|
|
2014
Q2 | $44.2M | Buy |
1,281,700
+280,700
| +28% | +$8.84M | 0.02% | 785 |
|
|
2014
Q1 | $43.3M | Buy |
1,001,000
+132,800
| +15% | +$6.44M | 0.02% | 708 |
|
|
2013
Q4 | $34.6M | Buy |
868,200
+354,800
| +69% | +$12.6M | 0.02% | 890 |
|
|
2013
Q3 | $19.3M | Buy |
513,400
+71,300
| +16% | +$2.13M | 0.01% | 1238 |
|
|
2013
Q2 | $11.9M | Buy |
+442,100
| New | +$9.4M | 0.01% | 1594 |
|
Other funds holding IONS
VPM
VCM
Susquehanna International Group's IONS Position: Q1 2026 in Review
Susquehanna International Group reduced its Ionis Pharmaceuticals (IONS) stake by 62% in Q1 2026, selling an estimated $1.59M and leaving 12,359 shares worth $928K. The position accounts for ﹤0.01% of the portfolio, ranked #8076.
Susquehanna International Group first reported a position in IONS in Q2 2013 and has held it in 49 quarters since. The position peaked at $36.5M in Q2 2015. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Susquehanna International Group held 12,359 shares of Ionis Pharmaceuticals worth $928K as of Q1 2026.
- Susquehanna International Group sold 20,145 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.59M.
- Ionis Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8076 holding.
- Susquehanna International Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's Ionis Pharmaceuticals position peaked at $36.5M in Q2 2015.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.